Evidence map›Paper›PMID 34169495›Full record

ArticleThrombosis and haemostasis2021

The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper.

Grigoris T Gerotziafas, Mariella Catalano, Yiannis Theodorou, Patrick Van Dreden, Vincent Marechal, Alex C Spyropoulos, Charles Carter, Nusrat Jabeen, Job Harenberg, Ismail Elalamy and 48 more

Registry-linked trialOpen access · hybridAbstract readConsensus Statement
In one paragraph

Article in Thrombosis and haemostasis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05242549 (Application of the Transtheoretical Model to Physical Activity and Health-related Quality of Life Among the Frailty of the Community Elderly), which is not on this map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05242549 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Application of the Transtheoretical Model to Physical Activity and Health-related Quality of Life Among the Frailty of the Community Elderly

TypeinterventionalSponsorNational Taipei University of Nursing and Health SciencesRan2022 to 2023Enrolled84ConditionsFrailtyArmsFitness and Nutrition Program for Seniors
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. An Application ofJournal of evidence-based integrative medicine
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

58 authors at 20 institutions in 28 countries.

Grigoris T GerotziafasSorbonne Université, INSERM, UMR_S 938, Research Group Cancer, Biology and Therapeutics, Centre de recherche Saint-Antoine (CRSA), Institut Universitaire de Cancérologie, Paris, France.ORCID 0000-0003-2316-6348
Mariella CatalanoResearch Center on Vascular Disease & Angiology Unit, Department of Biomedical Science, L Sacco Hospital, University of Milan, Milan, Italy.
Yiannis TheodorouCentre d'Immunologie et des Maladies Infectieuses UPMC UMRS CR7, Inserm U1135, CNRS ERL 8255, Paris, France.
Patrick Van DredenSorbonne Université, INSERM, UMR_S 938, Research Group Cancer, Biology and Therapeutics, Centre de recherche Saint-Antoine (CRSA), Institut Universitaire de Cancérologie, Paris, France.
Vincent MarechalSorbonne Université, INSERM, UMR_S 938, Research Group Cancer, Biology and Therapeutics, Centre de recherche Saint-Antoine (CRSA), Institut Universitaire de Cancérologie, Paris, France.
Alex C SpyropoulosDonald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, United States.
Charles CarterDepartment of Clinical Research, College of Pharmacy & Health Sciences, Campbell University, Buies Creek, North Carolina, United States.
Nusrat JabeenDepartment of Microbiology, University of Karachi, Karachi, Pakistan.
Job HarenbergDepartment for Physical Chemistry, Heidelberg University, Heidelberg, Germany.
Ismail ElalamySorbonne Université, INSERM, UMR_S 938, Research Group Cancer, Biology and Therapeutics, Centre de recherche Saint-Antoine (CRSA), Institut Universitaire de Cancérologie, Paris, France.
Anna FalangaImmunohematology and Transfusion Medicine Department, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy.ORCID 0000-0002-5007-3457
Jawed FareedDepartment of Pathology and Laboratory Medicine, Cardiovascular Research Institute, Health Sciences Division, Loyola University Chicago, Maywood, Illinois, United States.
Petros AgathaggelouCyprus Department of Interventional Cardiology, American Heart Institute of Cyprus, Nicosia, Cyprus.
Darko AnticClinic of Hematology, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Pier Luigi AntignaniVascular Center, Nuova Villa Claudia, Rome, Italy.
Manuel Monreal BoschDepartment of Internal Medicine, Hospital Universitario Germans Trias i Pujol de Badalona, Universidad Católica de Murcia, Murcia, Spain.
Benjamin BrennerThrombosis and Hemostasis Unit, Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel.
Vladimir ChekhoninDepartment of Fundamental and Applied Neurobiology, V. P. Serbsky Federal Medical Research Centre of Psychiatry and Narcology, Ministry of Health of the Russian Federation, Moscow, Russia.
Mary-Paula ColganDepartment of Vascular Surgery, St. James's Hospital/Trinity College Dublin, Dublin, Ireland.
Meletios-Athanasios DimopoulosDepartment of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Jim DouketisDivision of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Essam Abo ElnazarDepartment of Surgery, Ministry of Health, Saudi Arabia.
Katalin FarkasDepartment of Angiology, St. Imre University Teaching Hospital, Budapest, Hungary.
Bahare FazeliImmunology Department, Avicenna (Bu-Ali) Research Institute, Mashhad University of Medical Sciences, Iran.
Gerry FowkesUsher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, United Kingdom.
Yongquan GuDepartment of Vascular Surgery, Xuan Wu Hospital, Capital Medical University and Institute of Vascular Surgery, Capital Medical University, Beijing, China.
Joseph GligorovSorbonne Université, INSERM, UMR_S 938, Research Group Cancer, Biology and Therapeutics, Centre de recherche Saint-Antoine (CRSA), Institut Universitaire de Cancérologie, Paris, France.
Mark A LigockiDepartment of Pathology and Laboratory Medicine, Cardiovascular Research Institute, Health Sciences Division, Loyola University Chicago, Maywood, Illinois, United States.
Tishya IndranAustralia Department of Haematology, Monash Health, Clayton, Victoria, Australia.
Meganathan KannanDivision of Blood and Vascular Biology, Department of Life Sciences, School of Life Sciences, Central University of Tamil Nadu, Thiruvarur, India.
Bulent KantarciogluDepartment of Hematology, Okmeydani Training and Research Hospital, Istanbul, Turkey.
Abdoul Aziz KasseInstitut du Cancer UCAD, Centre International de Cancérologie de Dakar, Dakar, Senegal.
Kostantinos Konstantinidis5th Surgical Department, Group of Vascular Surgery, Hippokrateio General University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Fabio LeivanoDepartment of Pharmacology and Neuroscience, Cardiovascular Research Institute, Health Sciences Division, Loyola University Chicago, Maywood, Illinois, United States.
Joseph LewisDepartment of Surgery, Stony Brook Southampton Hospital, Southampton, New York, United States.
Alexander MakatsariyaDepartment of Obstetrics and Gynecology, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia.
P Massamba MbayeUniversité Virtuelle du Sénégal, Dakar, Senegal.
Isabelle MahéInnovative Therapies in Haemostasis, Hôpital Louis Mourier, APHP, Colombes, Université de Paris, INSERM, F-75006 Paris, France.
Irina Panovska-StavridisUniversity Clinic of Hematology, Skopje, Republic of North Macedonia.
Dan-Mircea OlinicMedical Clinic No. 1, University of Medicine and Pharmacy, Cluj-Napoca, Romania.
Chryssa PapageorgiouService Anesthésie, Réanimation et Médecine Périopératoire, Hôpital Tenon, Hôpitaux Universitaires de l'Est Parisien, Assistance Publique Hôpitaux de Paris, Faculté de médecine, Sorbonne Université, Paris, France.
Zsolt PecsvaradyDepartment of Vascular Medicine, Flor Ferenc Teaching Hospital, Kistarcsa, Hungary.
Sergio PillonUOSD Angiology, San Camillo-Forlanini Hospital, National Health Institute ISS, AO San Camillo Forlanini, Rome, Italy.
Eduardo RamacciottiHemostasis & Thrombosis Research Laboratories, Loyola University Medical Center, Maywood, Illinois, United States.
Hikmat Abdel-RazeqDepartment of Internal Medicine, King Hussein Cancer Center, Amman, Jordan.
Michele SabbahSorbonne Université, INSERM, UMR_S 938, Research Group Cancer, Biology and Therapeutics, Centre de recherche Saint-Antoine (CRSA), Institut Universitaire de Cancérologie, Paris, France.
Mouna SassiLaboratoire de Biologie, Centre de Maternité et de Néonatologie, Hôpital Fattouma Bourguiba, Monastir, Tunisia.
Gerit SchernthanerDivision of Angiology, Department of Internal Medicine 2, Medical University of Vienna, Vienna, Austria.
Fakiha SiddiquiCardiovascular Research Institute, Health Sciences Divisions, Loyola University Chicago, Maywood, Illinois, United States.
Jin ShiomuraNobelpharma Co. Ltd., Chuo-ku, Tokyo, Japan.
Anny Slama-SchwokSorbonne Université, INSERM, UMR_S 938, Research Group Cancer, Biology and Therapeutics, Centre de recherche Saint-Antoine (CRSA), Institut Universitaire de Cancérologie, Paris, France.
Jean Claude WautrechtService de Pathologie Vasculaire, Hôpital ERASME, Université Libre de Bruxelles, Brussels, Belgium.
Alfonso TafurVascular Medicine, Northshore Cardiovascular Institute, Skokie, Illinois, United States.
Ali TaherDivision of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Peter Klein-WegelKlinik für Angiologie, Zentrum für Innere Medizin II, Ernst von Bergmann Klinikum, Potsdam, Germany.
Zenguo ZhaiCenter of Respiratory Medicine, Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, Peking University Health Science Center, Capital Medical University, Beijing, China.
Tazi Mezalek ZoubidaClinical Hematology - Internal Medicine, Ibn Sina hospital, Mohammed V University, -Rabat, Morocco.
Scientific Reviewer Committee
Inserm · FRLoyola University Chicago · USSechenov University · RUAmerican Heart Institute · CYAmerican University of Beirut Medical Center · LBAristotle University of Thessaloniki · GRCampbell University · USCapital Medical University · CNCarlo Forlanini Hospital · ITCentral University of Tamil Nadu · INCentre National de la Recherche Scientifique · FRHeidelberg University · DEHospital Fatuma Bourguiba Monastir · TNKing Hussein Cancer Center · JOKlinikum Ernst von Bergmann · DELoyola University Medical Center · USMashhad University of Medical Sciences · IRMedical University of Vienna · ATMinistry of Health · SAMinistry of Health of the Russian Federation · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOne year after the declaration of the coronavirus disease 2019 (COVID-19) pandemic by the World Health Organization (WHO) and despite the implementation of mandatory physical barriers and social distancing, humanity remains challenged by a long-lasting and devastating public health crisis. MANAGEMENT: Non-pharmacological interventions (NPIs) are efficient mitigation strategies. The success of these NPIs is dependent on the approval and commitment of the population. The launch of a mass vaccination program in many countries in late December 2020 with mRNA vaccines, adenovirus-based vaccines, and inactivated virus vaccines has generated hope for the end of the pandemic. CURRENT ISSUES: The continuous appearance of new pathogenic viral strains and the ability of vaccines to prevent infection and transmission raise important concerns as we try to achieve community immunity against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) and its variants. The need of a second and even third generation of vaccines has already been acknowledged by the WHO and governments. PERSPECTIVES: There is a critical and urgent need for a balanced and integrated strategy for the management of the COVID-19 outbreaks organized on three axes: (1)

conclusionThe "PDA strategy" integrated into state policy for the support and expansion of health systems and introduction of digital organizations (i.e., telemedicine, e-Health, artificial intelligence, and machine-learning technology) is of major importance for the preservation of citizens' health and life world-wide.

Indexed as

Public HealthCOVID-19COVID-19 TestingCOVID-19 VaccinesDisease ManagementHumansImmunization ProgramsPandemicsRisk AssessmentSARS-CoV-2COVID-19 Vaccines

Identifiers

PMID34169495
PMCPMC8322591
OpenAlexW3174421674

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.